logo

For the Inventor, By the Inventor

Newark, DE, United States of America

Ibio Limited

Calculating rank
USPTO Granted Patents = 23

% Expired Patents = 26.1



Trademarks = 6

Forward Citations = 46

Loading Chart...
Loading Chart...

49 inventors (with patents filed for the assignee):

goldMedal Vidadi Yusibov (15 out of 30 patents)

silverMedal Vadim Mett (9 out of 22 patents)

bronzeMedal Shailaja Rabindran (5 out of 7 patents)

4.  Oleg Fedorkin (4 out of 6 patents)

5.  Konstantin Musiychuk (3 out of 7 patents)

6.  Matthew Paul Greving (3 out of 8 patents)

7.  Phung Tu Gip (3 out of 3 patents)

8.  Mohan Srinivasan (2 out of 78 patents)

9.  Jessica Chichester (2 out of 2 patents)

10.  Lauren Goldschmidt (2 out of 2 patents)

11.  Yoko Shoji (2 out of 2 patents)

12.  Burt D Ensley (2 out of 18 patents)

13.  Kevin Eduard Hauser (2 out of 2 patents)

14.  Ramesh Baliga (1 out of 29 patents)

15.  Angeles Estelles (1 out of 11 patents)


23 patents:

1. 12473368 - CD25 Antibodies (2025-11-18),
2. 12441803 - Engineered CD25 polypeptides and uses thereof (2025-10-14),
3. 12215163 - CD25 antibodies (2025-02-04),
4. 12129302 - Anti-CD-25 antibody (2024-10-29),
5. 11673926 - In vivo de-glycosylation of recombinant proteins by co-expression with PNGase F (2023-06-13),
6. 11545238 - Machine learning method for protein modelling to design engineered peptides (2023-01-03),
7. 10844392 - Materials and methods for producing endostatin fusion polypeptides in plant cells (2020-11-24),
8. 9809644 - Influenza hemagglutinin antibodies, compositions and related methods (2017-11-07),
9. 9765349 - System for expression of genes in plants (2017-09-19),
10. 9551001 - System for expression of genes in plants (2017-01-24),
11. 9115201 - Humanized neuraminidase antibody and methods of use thereof (2015-08-25),
12. 9012199 - Recombinant carrier molecule for expression, delivery and purification of target polypeptides (2015-04-21),
13. 8962278 - Compositions and methods for production of immunoglobulins (2015-02-24),
14. 8951791 - System for expression of genes in plants (2015-02-10),
15. 8945580 - [object Object] (2015-02-03),
Company Overview
Ibio Limited is a biotechnology company based in Newark, Delaware, specializing in the development of innovative plant-based biopharmaceuticals. The company focuses on leveraging its proprietary technology platform to produce therapeutic proteins and vaccines efficiently. With a commitment to advancing healthcare solutions, Ibio is engaged in research and development across various therapeutic areas, aiming to address unmet medical needs through its unique approach to biologics manufacturing.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

Ibio Limited USPTO Patent Assignee Logo
23 Patents

#15 in Newark, DE

#246 in Delaware

#14,438 in US

#27,714 in the World

Newark, DE (US)
Newark, DE, United States of America

Ibio Limited

Forward Citations = 46

49 inventors:

goldMedal Vidadi Yusibov (15 out of 30 patents)

silverMedal Vadim Mett (9 out of 22 patents)

bronzeMedal Shailaja Rabindran (5 out of 7 patents)

4.  Oleg Fedorkin (4 out of 6 patents)

5.  Konstantin Musiychuk (3 out of 7 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Ibio Limited. Retrieved from https://idiyas.com/company/ibio

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…